¼¼°èÀÇ Àü»çüÇÐ ½ÃÀå º¸°í¼­(2025³â)
Transcriptomics Global Market Report 2025
»óǰÄÚµå : 1760731
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,312,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,124,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,936,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Àü»çüÇÐ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â¿¡´Â 8.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 96¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ¼ºÀåÀº ´ÜÀÏ ¼¼Æ÷ ¸®º¸ÇÙ»ê ¼­¿­ÀÇ Ã¤Åà Áõ°¡, °ø°£ Àü»çüÇÐÀÇ ÅëÇÕ Áõ°¡, ¸ÖƼ¿À¹Í½º Á¢±Ù¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, Áúº´ÀÇ Á¶±â ¹ß°ß¿¡ ´ëÇÑ °ü½É Áõ°¡, ºñÄÚµå ¸®º¸ÇÙ»êÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·ç¾îÁú °ÍÀÔ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS) ±â¼úÀÇ ¹ßÀü, °ø°£Àû Àü»çüÇÐÀÇ Çõ½Å, »ý¹°Á¤º¸ÇÐ µµ±¸ÀÇ °³¼±, Àü»çüÇп¡ ¸Ó½Å·¯´×ÀÇ ÅëÇÕ, ½Ç½Ã°£ Àü»çü ºÐ¼® ±â¼úÀÇ ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù.

¸ÂÃãÇü ÀÇ·áÀÇ Ã¤Åà Ȯ´ë°¡ ÇâÈÄ Æ®·£½º½ºÅ©¸³¹Í½º ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸ÂÃãÀÇ·á´Â °³ÀÎÀÇ À¯ÀüÀû üÁú, »ýȰ½À°ü, ȯ°æÀû ¿äÀο¡ µû¶ó ¸ÂÃãÇü Ä¡·á¸¦ Á¦°øÇÏ´Â °ÍÀ» ÀǹÌÇÕ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀº À¯ÀüÀÚ ¿°±â¼­¿­ ºÐ¼®ÀÇ ¹ßÀüÀ¸·Î °³ÀÎÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ¸Â´Â Ä¡·á°¡ °¡´ÉÇØÁ® ´õ ³ôÀº È¿°ú¸¦ ¾òÀ» ¼ö ÀÖ°Ô µÇ¾ú±â ¶§¹®¿¡ ¸¹Àº ÁöÁö¸¦ ¹Þ°í ÀÖ½À´Ï´Ù. Æ®·£½º½ºÅ©¸³Æ½½º´Â °íÀ¯ÇÑ À¯ÀüÀÚ ¹ßÇö ÆÐÅÏÀ» ¹àÇô³¿À¸·Î½á º¸´Ù È¿°úÀûÀÌ°í ºÎÀÛ¿ëÀ» ÁÙÀ̸ç, Áúº´ÀÇ Á¶±â Áø´ÜÀ» Áö¿øÇÏ´Â °³ÀÎ ¸ÂÃãÇü Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù °³ÀθÂÃãÀǷῬÇÕ(Personalized Medicine Coalition)Àº FDA°¡ 2023³â Èñ±ÍÁúȯ¿¡ ´ëÇÑ 16°ÇÀÇ »õ·Î¿î °³ÀθÂÃãÇü Ä¡·áÁ¦¸¦ ½ÂÀÎÇß´Ù°í º¸°íÇß½À´Ï´Ù. ±× °á°ú, ¸ÂÃãÇü ÀÇ·áÀÇ º¸±ÞÀÌ Æ®·£½º½ºÅ©¸³¹Í½º ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Æ®·£½ºÅ©¸³Æ½½º ½ÃÀå ¾÷üµéÀº ¼¼Æ÷ ±â´É ¹× Áúº´ ¸ÞÄ¿´ÏÁò¿¡ ´ëÇÑ ´õ ±íÀº ÅëÂû·ÂÀ» ¾ò±â À§ÇØ ´ÜÀÏ ¼¼Æ÷ °ø°£ ÆÐ³Î°ú °°Àº Çõ½ÅÀûÀÎ Á¦Ç° °³¹ß¿¡ ÁýÁßÇϰí ÀÖ½À´Ï´Ù. ´ÜÀÏ ¼¼Æ÷ °ø°£ ÆÐ³ÎÀº Á¶Á÷ ³» ¼¼Æ÷ÀÇ À§Ä¡¸¦ À¯ÁöÇϸ鼭 °³º° ¼¼Æ÷ ¼öÁØ¿¡¼­ À¯ÀüÀÚ ¹ßÇöÀ» ºÐ¼®ÇÕ´Ï´Ù. ÀÌ ÆÐ³ÎÀº ´ÜÀÏ ¼¼Æ÷ Àü»çü ºÐ¼®°ú °ø°£ µ¥ÀÌÅ͸¦ °áÇÕÇÏ¿© ¼¼Æ÷ Ȱµ¿°ú Á¶Á÷ ±¸Á¶¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù NanoString Technologies´Â CosMx 6,000 plex RNA Assay¸¦ Ãâ½ÃÇß½À´Ï´Ù. CosMx Spatial Molecular Imager(SMI) ¿ëÀ¸·Î ¼³°èµÈ ÀÌ È¹±âÀûÀÎ Á¦Ç°Àº °ÅÀÇ ¸ðµç Àΰ£ »ý¹°ÇÐÀû °æ·Î¿¡ °ÉÃÄ 6,000°³ ÀÌ»óÀÇ RNA Ÿ°ÙÀ» ÃøÁ¤ÇÒ ¼ö ÀÖ´Â ÃÖÃÊÀÇ »ó¾÷¿ë ´ÜÀÏ ¼¼Æ÷ °ø°£ ÆÐ³ÎÀÔ´Ï´Ù. ¼¼ºÐÈ­¸¦ ÅëÇØ ´ÜÀÏ ¼¼Æ÷ ¹× ¼¼Æ÷ ³» ÇØ»óµµ·Î À¯ÀüÀÚ ÇÁ·ÎÆÄÀϸµÀ» ¼öÇàÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í ÄڷγªÀç³­°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Transcriptomics is the study of all ribonucleic acid (RNA) transcripts generated by the genome within a specific cell, tissue, or condition. It aids in deciphering gene expression patterns and regulatory processes, revealing how they change in response to diseases or environmental influences. This field provides valuable insights into cellular functions and disease mechanisms. Transcriptomics plays a key role in biomarker discovery, identifying therapeutic targets, and advancing personalized medicine.

The primary categories of transcriptomics include instruments, consumables, software, and services. Instruments are vital in transcriptomics as they allow for the precise analysis of gene expression through high-throughput sequencing, amplification, and RNA detection. Various technologies are employed, such as microarrays, real-time quantitative polymerase chain reaction, and sequencing technologies. These tools are used for multiple applications, including diagnostics, disease profiling, drug discovery, and others, and are utilized by a wide range of end-users, such as academic and research institutions, pharmaceutical companies, biotechnology firms, and more.

The transcriptomics market research report is one of a series of new reports from The Business Research Company that provides transcriptomics market statistics, including the transcriptomics industry global market size, regional shares, competitors with the transcriptomics market share, detailed transcriptomics market segments, market trends, and opportunities, and any further data you may need to thrive in the transcriptomics industry. This transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transcriptomics market size has grown strongly in recent years. It will grow from $6.51 billion in 2024 to $7.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the past can be attributed to an increasing emphasis on personalized medicine, a rising prevalence of cancer, the incorporation of genomics in clinical diagnostics, the expansion of ribonucleic acid sequencing, and a growing demand for biomarker discovery.

The transcriptomics market size is expected to see strong growth in the next few years. It will grow to $9.65 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The expected growth in the forecast period is driven by the rising adoption of single-cell ribonucleic acid sequencing, the increasing integration of spatial transcriptomics, the growing demand for multiomics approaches, a heightened focus on early disease detection, and greater awareness of the significance of non-coding ribonucleic acids. Key trends for the forecast period include advancements in next-generation sequencing (NGS) technologies, innovations in spatial transcriptomics, improvements in bioinformatics tools, the integration of machine learning in transcriptomics, and progress in real-time transcriptomic analysis technologies.

The growing adoption of personalized medicine is expected to drive the growth of the transcriptomics market in the future. Personalized medicine involves customizing treatments based on an individual's genetic makeup, lifestyle, and environmental factors. This approach is gaining traction due to advancements in genetic sequencing, which allow for treatments tailored to a person's genetic profile for greater effectiveness. Transcriptomics helps uncover unique gene expression patterns, enabling personalized treatments that are more effective, reduce side effects, and support early disease diagnosis. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, compared to just six in 2022. As a result, the increasing adoption of personalized medicine is contributing to the growth of the transcriptomics market.

Companies in the transcriptomics market are focused on developing innovative products such as single-cell spatial panels to gain deeper insights into cellular functions and disease mechanisms. Single-cell spatial panels analyze gene expression at the individual cell level while preserving the cells' positions within the tissue. These panels combine single-cell transcriptomics with spatial data, providing insights into both cellular activity and tissue structure. For instance, in February 2024, NanoString Technologies launched the CosMx 6,000 plex RNA Assay, the first commercial single-cell spatial panel capable of measuring over 6,000 RNA targets across nearly all human biological pathways. This breakthrough, designed for use with the CosMx Spatial Molecular Imager (SMI), enables researchers to profile genes at single-cell and subcellular resolution with high accuracy and advanced cell segmentation.

In July 2024, Illumina, Inc., a U.S.-based provider of DNA sequencing and array-based technologies, acquired Fluent BioSciences for an undisclosed amount. This acquisition aims to enhance Illumina's multiomics capabilities by integrating Fluent's innovative, scalable single-cell technology, which eliminates the need for complex and expensive equipment. This enables faster, more cost-effective, and comprehensive discoveries in genomics and cell biology. Fluent BioSciences specializes in single-cell analysis technology, a key method in transcriptomics that allows researchers to profile gene expression at the individual cell level.

Major players in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, and Arraystar Inc.

North America was the largest region in the transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transcriptomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transcriptomics market consists of revenues earned by entities by providing services such as voice gene expression analysis, ribonucleic acid sequencing, bioinformatics solutions, and data interpretation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The transcriptomics market also includes sales of RNA extraction kits, library preparation kits, and cDNA synthesis kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transcriptomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for transcriptomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transcriptomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Transcriptomics Market Characteristics

3. Transcriptomics Market Trends And Strategies

4. Transcriptomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Transcriptomics Growth Analysis And Strategic Analysis Framework

6. Transcriptomics Market Segmentation

7. Transcriptomics Market Regional And Country Analysis

8. Asia-Pacific Transcriptomics Market

9. China Transcriptomics Market

10. India Transcriptomics Market

11. Japan Transcriptomics Market

12. Australia Transcriptomics Market

13. Indonesia Transcriptomics Market

14. South Korea Transcriptomics Market

15. Western Europe Transcriptomics Market

16. UK Transcriptomics Market

17. Germany Transcriptomics Market

18. France Transcriptomics Market

19. Italy Transcriptomics Market

20. Spain Transcriptomics Market

21. Eastern Europe Transcriptomics Market

22. Russia Transcriptomics Market

23. North America Transcriptomics Market

24. USA Transcriptomics Market

25. Canada Transcriptomics Market

26. South America Transcriptomics Market

27. Brazil Transcriptomics Market

28. Middle East Transcriptomics Market

29. Africa Transcriptomics Market

30. Transcriptomics Market Competitive Landscape And Company Profiles

31. Transcriptomics Market Other Major And Innovative Companies

32. Global Transcriptomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transcriptomics Market

34. Recent Developments In The Transcriptomics Market

35. Transcriptomics Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â